You are here
Coronavirus (COVID-19): Information on medicines and medical devices
The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.
Please read the information below before contacting the TGA to see if your question is already answered.
Filters
Topics and product types
I want to
- Find out about medicine shortages and restrictions (5) Apply Find out about medicine shortages and restrictions filter
- Report a perceived breach or questionable practices (1) Apply Report a perceived breach or questionable practices filter
- Supply a COVID-19 test kit (7) Apply Supply a COVID-19 test kit filter
- Supply a face mask, gloves or gown (2) Apply Supply a face mask, gloves or gown filter
- Supply hand sanitiser, cleaner or disinfectant (6) Apply Supply hand sanitiser, cleaner or disinfectant filter
Audience
- Advertisers (147) Apply Advertisers filter
- Consumers (193) Apply Consumers filter
- Remove Health professionals filter Health professionals (200)
- Manufacturers (184) Apply Manufacturers filter
- Remove Sponsors filter Sponsors (203)
Filters applied:
- (-) Remove Sponsors filter Sponsors
- (-) Remove Health professionals filter Health professionals
19 May 2022
At the time of approving a vaccine, the TGA publishes extensive information about the product for both health professionals and the public.
19 May 2022
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
17 May 2022
COVID-19 vaccines undergoing evaluation for provisional registration by the TGA
17 May 2022
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
16 May 2022
Find out which vaccines we recognise for the purpose of travel to Australia.
16 May 2022
COVID-19 vaccine batch release information is now available.
16 May 2022
The TGA is undertaking a post-market review of all face masks included in the Australian Register of Therapeutic Goods to ensure the quality and effectiveness of face masks.
13 May 2022
The TGA has received and commenced evaluation of an application to extend the use of its COVID-19 vaccine, SPIKEVAX, to children aged 6 months to 5 years old.
13 May 2022
The TGA has determined that the BBIBP-CorV (Sinopharm) COVID-19 vaccine will be 'recognised' for all ages for the purpose of establishing a traveller's vaccination status when entering Australia.
6 May 2022
COVID-19 treatments undergoing evaluation for provisional registration by the TGA
Pages
Further information
Contact TGA Info
Tel: 1800 020 653
Email: info@tga.gov.au
Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.
Department of Health
Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.
Follow us
